Cargando…

Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use

Background. Cancer survivors use complementary therapies (CTs) for a variety of reasons; however, with interest and use reportedly on the rise and a widening range of products and practices available, there is a need to establish trends in and drivers of interest. We aimed to determine (1) frequenci...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Maryam, Zelinski, Erin, Carlson, Linda E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142098/
https://www.ncbi.nlm.nih.gov/pubmed/29629606
http://dx.doi.org/10.1177/1534735418762496
_version_ 1783355806108876800
author Qureshi, Maryam
Zelinski, Erin
Carlson, Linda E.
author_facet Qureshi, Maryam
Zelinski, Erin
Carlson, Linda E.
author_sort Qureshi, Maryam
collection PubMed
description Background. Cancer survivors use complementary therapies (CTs) for a variety of reasons; however, with interest and use reportedly on the rise and a widening range of products and practices available, there is a need to establish trends in and drivers of interest. We aimed to determine (1) frequencies of use, level of interest, and barriers for 30 specific CTs and (2) whether physical symptoms, perceived stress (PS), or spiritual well-being were related to interest levels. Method. A total of 212 cancer outpatients were surveyed at the Tom Baker Cancer Centre in Calgary, Canada. Results. Overall, up to 75% of survivors already used some form of CTs since their diagnosis. The most highly used were the following: vitamins B12 and D, multivitamins, calcium, and breathing and relaxation exercises. Those who had not used CTs indicated highest interest in massage, vitamin B12, breathing and relaxation, mindfulness-based stress reduction, and antioxidants. The most frequently reported barriers for all CTs were not knowing enough about what a therapy was and not having enough evidence on whether it worked. High PS predicted higher interest for all CTs, but spirituality was not significantly related to any. Physical symptoms, anxiety, and depression were significant predictors of interest for some CTs. Conclusion. These findings provide a blueprint for future clinical efficacy trials and highlight the need for clinical practice guidelines.
format Online
Article
Text
id pubmed-6142098
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61420982018-09-20 Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use Qureshi, Maryam Zelinski, Erin Carlson, Linda E. Integr Cancer Ther Research Articles Background. Cancer survivors use complementary therapies (CTs) for a variety of reasons; however, with interest and use reportedly on the rise and a widening range of products and practices available, there is a need to establish trends in and drivers of interest. We aimed to determine (1) frequencies of use, level of interest, and barriers for 30 specific CTs and (2) whether physical symptoms, perceived stress (PS), or spiritual well-being were related to interest levels. Method. A total of 212 cancer outpatients were surveyed at the Tom Baker Cancer Centre in Calgary, Canada. Results. Overall, up to 75% of survivors already used some form of CTs since their diagnosis. The most highly used were the following: vitamins B12 and D, multivitamins, calcium, and breathing and relaxation exercises. Those who had not used CTs indicated highest interest in massage, vitamin B12, breathing and relaxation, mindfulness-based stress reduction, and antioxidants. The most frequently reported barriers for all CTs were not knowing enough about what a therapy was and not having enough evidence on whether it worked. High PS predicted higher interest for all CTs, but spirituality was not significantly related to any. Physical symptoms, anxiety, and depression were significant predictors of interest for some CTs. Conclusion. These findings provide a blueprint for future clinical efficacy trials and highlight the need for clinical practice guidelines. SAGE Publications 2018-04-09 /pmc/articles/PMC6142098/ /pubmed/29629606 http://dx.doi.org/10.1177/1534735418762496 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Articles
Qureshi, Maryam
Zelinski, Erin
Carlson, Linda E.
Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title_full Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title_fullStr Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title_full_unstemmed Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title_short Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
title_sort cancer and complementary therapies: current trends in survivors’ interest and use
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142098/
https://www.ncbi.nlm.nih.gov/pubmed/29629606
http://dx.doi.org/10.1177/1534735418762496
work_keys_str_mv AT qureshimaryam cancerandcomplementarytherapiescurrenttrendsinsurvivorsinterestanduse
AT zelinskierin cancerandcomplementarytherapiescurrenttrendsinsurvivorsinterestanduse
AT carlsonlindae cancerandcomplementarytherapiescurrenttrendsinsurvivorsinterestanduse